From $139/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.
Get startedHome / Sublingual tirzepatide
No needles. One flat price at every dose.
Medically reviewed by the NexLife clinical team, led by Adam Kennah, MD (NPI 1144260043) · Updated
NexLife’s compounded sublingual tirzepatide tablets are $199 a month on a 12-month plan or $229 month to month, the same at every dose, with care and shipping included. There’s no FDA-approved tirzepatide pill: Zepbound and Mounjaro are weekly injections. Compounded tablets aren’t FDA-approved, and how well they’re absorbed hasn’t been through FDA review.
Tablets from $199/mo at every dosePrice Match Guarantee†
$199/mo for tablets on a 12-month plan, all-inclusive, same price at every dose
Or $229/mo month to month
Weekly injections: $139/mo on a 12-month plan, $169 month to month
About 3 minutes online. Compounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.
Price Match Guarantee. Paying less elsewhere? We match your regular monthly price.† How it works
Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.
The short answer
Not an FDA-approved one. Tirzepatide is approved as a weekly injection, and the tablets you’ll find online are compounded.
Tirzepatide is FDA-approved only as a once-weekly injection under the skin: Zepbound for weight and Mounjaro for type 2 diabetes.
Lilly’s once-daily pill, Foundayo, is orforglipron, a different medicine, approved by the FDA on April 1, 2026. See our Foundayo guide for its doses and price.
Some programs, NexLife included, offer compounded tirzepatide tablets that dissolve under the tongue. NexLife’s are $199 a month on a 12-month plan or $229 month to month. They aren’t FDA-approved.
ODT stands for orally dissolving tablet. It’s the same idea: a compounded tablet that melts in the mouth instead of a shot. A licensed provider decides if it’s right for you.
“Zepbound is administered by injection under the skin once weekly, and the dosage must be increased over four to 20 weeks to achieve the target dosages of 5 milligram (mg), 10 mg or 15 mg once weekly. The maximum dosage of Zepbound is 15 mg once weekly.”
Tablets vs. injections
The medicine’s name is the same. The way it gets into your body, the evidence behind it and the price are not. For every
| Sublingual tablet (compounded) | Weekly injection (compounded) | Zepbound (FDA-approved) | |
|---|---|---|---|
| How you take it | Dissolves under the tongue | A shot under the skin, once a week | A shot under the skin, once a week |
| Needles | None | Yes, a vial and syringe | Yes, a pen or a vial and syringe |
| FDA-approved | No | No | Yes |
| Evidence behind it | No FDA-reviewed trials of the tablet form | Zepbound’s trials only; compounded products weren’t studied | The trials the FDA reviewed for approval |
| Price | $199 a month on 12 months, $229 month to month, at NexLife | $139 a month on 12 months, $169 month to month, at NexLife | $299 to $449 a month by dose at LillyDirect (self-pay) |
Swipe the table sideways to see every column.
NexLife prices are ours, at every dose. Zepbound at Lilly’s self-pay price with on-time refills, checked October 15, 2026. Compounded tirzepatide, as a tablet or an injection, isn’t FDA-approved; Zepbound is.
“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”
Price
At NexLife, $199 a month on a 12-month plan or $229 month to month, the same at every dose, all in. Here’s how that sits next to our injections and other programs’ tablets.
Compounded tirzepatide at NexLife, per month, all in, the same at every dose. Tablets cost $60 a month more than injections on either plan. Compounded medications aren’t FDA-approved.
| Program | Month to month | Longer plan | Same price at every dose |
|---|---|---|---|
| NexLifesublingual tablets | $229 | $199 a month on a 12-month plan | Yes |
| Raelivaoral dissolving tablets | $359 | $267 a month on a 6-month plan ($1,600 every 6 months); $283 a month on 3 months ($850) | Yes, per its site |
| Henry Medsoral dissolving tablets | Not listed | $1,047 for a 3-month supply, or $891 if paid in full | Not stated |
Swipe the table sideways to see every column.
Compounded tirzepatide tablets, all in, from each company’s own site, checked October 19, 2026. Henry Meds lists its tablets as a 3-month supply of up to 6 mg, taken daily; there’s no month-to-month price to set beside the others. Compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you.
Comparing like for like. Month to month, NexLife’s tablets are $229 and Raeliva’s are $359.
On longer plans, the lengths differ. NexLife is $199 a month on a 12-month plan, Raeliva $267 a month on a 6-month plan, and Henry Meds’ 3-month supply works out to about $349 a month, or $297 if you pay in full. Your price at NexLife doesn’t change when your dose does.
Prefer the lower price? NexLife’s weekly injections are $139 a month on a 12-month plan, or $169 month to month: one of the two lowest flat month-to-month prices in our
Who it suits
Tablets are for people who want tirzepatide without needles and accept that the tablet form has less research behind it. Injections remain the form that was approved and studied.
Not for you, in any form, if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). Pregnant, planning to be or breastfeeding? Tell your provider first: tirzepatide may harm an unborn baby. Your provider goes through the rest of your health history with you and decides whether tirzepatide is right for you at all.
Weighing semaglutide too? NexLife’s sublingual semaglutide tablets are $165 a month on a 12-month plan or $199 month to month, at every dose. See how the two medicines compare in tirzepatide vs. semaglutide.
How it’s taken
It dissolves under your tongue, on the routine your prescription sets. Here’s what to expect, step by step.
You start with a short online health assessment, about 3 minutes. A licensed provider reviews it and decides whether tirzepatide is right for you, as a tablet or an injection, and at what dose.
That’s what sublingual means. The tablet is made to dissolve there rather than be swallowed with water.
How many tablets you take, and when, comes from your prescription and the pharmacy label. Your provider sets it for you, so we don’t print a one-size schedule here. Questions about it come to us, 24/7, at
$199 a month on a 12-month plan, or $229 month to month, at every dose. No membership fee.
FDA-approved
Safety
Tirzepatide’s known side effects come from injection trials. Tablets haven’t been studied the same way, so be cautious with any claim about them, including ours.
Start with what the FDA label for tirzepatide says. In the prescribing information for Zepbound, the injection, the most common side effects are stomach-related: nausea, diarrhea, vomiting and constipation. In the trials, most of them happened while the dose was going up. Serious problems, such as pancreatitis or gallbladder disease, are uncommon but need prompt care.
What that means for tablets. Those figures come from injection trials. Compounded tablets haven’t been studied that way, so nobody can tell you how often side effects happen with them. If something feels off, tell us: real people answer 24/7, and your provider can adjust your plan. Read more in tirzepatide side effects.
At NexLife
One monthly price: $199 on a 12-month plan or $229 month to month, at every dose, all in.
Reviews your health history, prescribes only if it’s right for you, and follows your dose.
A personalized
In the price, at every dose.
Call or text
$199 a month on a 12-month plan, $229 month to month. No membership fee.
HSA and FSA cards work, and there are pay-later options at checkout.
Paying less with another licensed provider? Our Price Match Guarantee matches your regular monthly price.† See how the price match works.
Both are prepared by state-licensed 503A partner pharmacies and shipped free. Your provider helps you decide which one fits.
From $139/mo
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.
Get startedFrom $119/mo
Weekly
Prescription required. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you. Prices checked October 15, 2026.
The NexLife Price Match Guarantee
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Facts
The facts in one place, as of .
| Sublingual tablets | Compounded tirzepatide tablets: $199 a month on a 12-month plan or $229 month to month; semaglutide tablets: $165 or $199. The same price at every dose. Not FDA-approved. |
|---|---|
| What NexLife is | A LegitScript-certified telehealth and care-coordination platform. A provider licensed in your state makes every prescribing decision. |
| Medications and prices | Compounded tirzepatide from $139 a month and compounded semaglutide from $119 a month on 12-month plans, or $169 and $139 month to month. The same price at every dose. |
| Included | Provider review, the medication, a personalized nutrition plan, a 1:1 coaching call, free expedited shipping and 24/7 support from real people. No membership fee. |
| Pharmacies | Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA): state-licensed 503A partner pharmacies. You never have to contact them; we do. |
| Medical oversight | Medical director Adam Kennah, MD (NPI 1144260043). Physicians answer medical questions during clinical hours. |
| Ratings | 4.8 out of 5 on Trustpilot. 5,000+ members served. |
| Price Match Guarantee | Paying less with another licensed U.S. telehealth provider or clinic? We match your regular all-in monthly price.† |
| Paying | HSA and FSA cards, plus pay-later options at checkout. |
| Important | Compounded medications are not FDA-approved. A provider prescribes one only when it offers a significant difference for you, and not everyone who applies is prescribed. |
| Contact |
Not as an FDA-approved medicine. Tirzepatide is approved only as a once-weekly injection: Zepbound for weight and Mounjaro for type 2 diabetes. Some programs, NexLife included, offer compounded tirzepatide tablets that dissolve under the tongue; NexLife’s are $199 a month on a 12-month plan or $229 month to month. They aren’t FDA-approved.
It’s compounded tirzepatide made as a tablet that dissolves under the tongue instead of being injected. A state-licensed pharmacy prepares it on a prescription. It isn’t FDA-approved, and no sublingual tirzepatide has been through FDA review.
ODT means orally dissolving tablet: a compounded tirzepatide tablet that dissolves in the mouth, under the tongue, rather than being swallowed or injected. It isn’t FDA-approved.
At NexLife, $199 a month on a 12-month plan or $229 month to month, the same at every dose, with provider care, a nutrition plan, a coaching call and shipping included. Raeliva lists $359 month to month, and Henry Meds $1,047 for a 3-month supply ($891 if paid in full), checked October 19, 2026. Compounded medications aren’t FDA-approved.
Not at NexLife. Weekly injections are $139 a month on a 12-month plan or $169 month to month; sublingual tablets are $199 or $229, $60 a month more on either plan.
Nobody can say yet. The weight-loss results you’ll read about come from trials of the injection, and no sublingual tirzepatide has been through FDA review. We don’t claim tablets work the same as injections.
No. The FDA has approved tirzepatide only as an injection. Compounded tablets, drops or other oral forms aren’t FDA-approved.
No. Foundayo is orforglipron, a different once-daily pill from Lilly, approved by the FDA on April 1, 2026. It isn’t tirzepatide.
No tirzepatide drop is FDA-approved. Some online programs sell compounded oral forms of
The tablet dissolves under your tongue. How many you take, and when, is set by your prescription and the pharmacy label. Questions come to NexLife, 24/7.
Possibly. It’s a new prescription, so a licensed provider reviews your history and decides the form and the dose. If your injections are working, there’s no need to switch.
No. NexLife’s sublingual tirzepatide is $199 a month on a 12-month plan, or $229 month to month, at every dose.
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety informationIn studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
Leads the NexLife clinical team, which medically reviewed this page on October 20, 2026.
NexLife and other programs’ tablet prices checked October 19, 2026.
Paying less elsewhere? We match it.†
Sublingual tablets from $199 a month on a 12-month plan, or $229 month to month. Weekly injections from $139. A licensed provider decides which form, if any, is right for you.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
A short online health assessment, about 3 minutes.
You’re prescribed only if treatment is right for you.
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.